Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting de Novo Pyrimidine Biosynthesis by Leflunomide as a Novel Concept for the Treatment of Corona Virus Disease 2019 (COVID-19)

NCT05007678 is registered in ClinicalTrials.gov with Ashford and St. Peter's Hospitals NHS Trust as lead sponsor.

NCT NCT05007678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide as a Novel Concept for the Treatment of Corona Virus Disease 2019 (COVID-19)
Lead sponsor
Ashford and St. Peter's Hospitals NHS Trust
Phase
Phase 3
Overall status
Completed
Start date
September 16, 2020
Completion date
July 1, 2022
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19